Pneumococcal vaccine efficacy for mucosal pneumococcal infections depends on Fcγ receptor IIa polymorphism

Vaccine

Volumn 24, Issue 6, 2006, Pages 792-797

  Wiertsema, Selma P ^a   Veenhoven, Reinier H ^b   Walraven, Vanessa ^a   Uiterwaal, Cuno S P M ^c   Schilder, Anne G M ^a   Rijkers, Ger T ^a   Sanders, Elisabeth A M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Infection and Immunology   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Fc receptors; Otitis media; Pneumococcal vaccinations

Indexed keywords

BACTERIUM ANTIBODY; FC GAMMA RECEPTOR 2A; FC RECEPTOR; GENOMIC DNA; HISTIDINE; IMMUNOGLOBULIN G ANTIBODY; PLACEBO; PNEUMOCOCCUS POLYSACCHARIDE; PNEUMOCOCCUS VACCINE; PNEUMUNE; UNCLASSIFIED DRUG;

ACUTE OTITIS MEDIA; ANTIBODY RESPONSE; ARTICLE; BACTERIUM CONJUGATION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG PROTEIN BINDING; FEMALE; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; STREPTOCOCCUS INFECTION;

ALLELES; ANTIGENS, CD; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFANT; MALE; MUCOUS MEMBRANE; PNEUMOCOCCAL VACCINES; POLYMORPHISM, GENETIC; RECEPTORS, IGG;

EID: 31944449933     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.08.029     Document Type: Article

References (34)

1. S. Black, H. Shinefield, B. Fireman, E. Lewis, P. Ray, J.R. Hansen Northern California Kaiser Permanente Vaccine Study Center Group Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children Pediatr Infect Dis J 19 3 2000 187 195
2. H.R. Shinefield, and S. Black Efficacy of pneumococcal conjugate vaccines in large scale field trials Pediatr Infect Dis J 19 4 2000 394 397
3. K.P. Klugman, S.A. Madhi, R.E. Huebner, R. Kohberger, N. Mbelle, and N. Pierce A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection N Engl J Med 349 14 2003 1341 1348
4. J. Eskola, T. Kilpi, A. Palmu, J. Jokinen, J. Haapakoski, and E. Herva Efficacy of a pneumococcal conjugate vaccine against acute otitis media N Engl J Med 344 6 2001 403 409
5. N. Mbelle, R.E. Huebner, A.D. Wasas, A. Kimura, I. Chang, and K.P. Klugman Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine J Infect Dis 180 4 1999 1171 1176
6. R. Dagan, N. Givon-Lavi, O. Zamir, M. Sikuler-Cohen, L. Guy, and J. Janco Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers J Infect Dis 185 7 2002 927 936
7. K. Hsu, S. Pelton, S. Karumuri, D. Heisey-Grove, and J. Klein Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine Pediatr Infect Dis J 24 1 2005 17 23
8. R.H. Veenhoven, D. Bogaert, A.G. Schilder, G.T. Rijkers, C.S. Uiterwaal, and H.H. Kiezebrink Nasopharyngeal pneumococcal carriage after combined pneumococcal conjugate and polysaccharide vaccination in children with a history of recurrent acute otitis media Clin Infect Dis 39 7 2004 911 919
9. L. Jodar, J. Butler, G. Carlone, R. Dagan, D. Goldblatt, and H. Kayhty Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants Vaccine 21 23 2003 3265 3272
10. L.H. Lee, C.E. Frasch, L.A. Falk, D.L. Klein, and C.D. Deal Correlates of immunity for pneumococcal conjugate vaccines Vaccine 21 17-18 2003 2190 2196
11. D.J. Barrett, and E.M. Ayoub IgG2 subclass restriction of antibody to pneumococcal polysaccharides Clin Exp Immunol 63 1 1986 127 134
12. A. Soininen, I. Seppala, T. Nieminen, J. Eskola, and H. Kayhty IgG subclass distribution of antibodies after vaccination of adults with pneumococcal conjugate vaccines Vaccine 17 15-16 1999 1889 1897
13. K.R. Lottenbach, C.M. Mink, S.J. Barenkamp, E.L. Anderson, S.M. Homan, and D.C. Powers Age-associated differences in immunoglobulin G1 (IgG1) and IgG2 subclass antibodies to pneumococcal polysaccharides following vaccination Infect Immun 67 9 1999 4935 4938
14. J.V. Ravetch, and S. Bolland IgG Fc receptors Annu Rev Immunol 19 2001 275 290
15. J.G. van de Winkel, and P.J. Capel Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications Immunol Today 14 5 1993 215 221
16. P.A. Warmerdam, J.G. van de Winkel, A. Vlug, N.A. Westerdaal, and P.J. Capel A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding J Immunol 147 4 1991 1338 1343
17. L.A. Sanders, J.G. van de Winkel, G.T. Rijkers, M.M. Voorhorst-Ogink, M. De Haas, and P.J. Capel Fc gamma receptor IIa (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections J Infect Dis 170 4 1994 854 861
18. W.L. van der Pol, T.W. Huizinga, G. Vidarsson, M.W. van der Linden, M.D. Jansen, and V. Keijsers Relevance of Fcgamma receptor and interleukin-10 polymorphisms for meningococcal disease J Infect Dis 184 12 2001 1548 1555
19. R. Veenhoven, D. Bogaert, C. Uiterwaal, C. Brouwer, H. Kiezebrink, and J. Bruin Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study Lancet 361 9376 2003 2189 2195
20. E.C. Breij, W.L. van der Pol, L. van Winsen, M.D. Jansen, C.D. Dijkstra, and J.G. van de Winkel No association of FcgammaRIIa, FcgammaRIIIa and FcgammaRIIIb polymorphisms with MS J Neuroimmunol 140 1-2 2003 210 215
21. L.A. Sanders, G.T. Rijkers, W. Kuis, A.J. Tenbergen-Meekes, B.R. Graeff-Meeder, and I. Hiemstra Defective antipneumococcal polysaccharide antibody response in children with recurrent respiratory tract infections J Allergy Clin Immunol 91 1 Pt 1 1993 110 119
22. L. Sanders, G. Rijkers, A. Tenbergen-Meekes, M. Voorhorst-Ogink, and B. Zegers Immunoglobulin isotype-specific antibody responses to pneumococcal polysaccharide vaccine in patients with recurrent bacterial respiratory tract infections Pediatr Res 37 1995 812 819
23. J. Gordon, and R.A. Murgita Suppression and augmentation of the primary in vitro immune response by different classes of antibodies Cell Immunol 15 2 1975 392 402
24. D.M. Musher, M.J. Luchi, D.A. Watson, R. Hamilton, and R.E. Baughn Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide J Infect Dis 161 4 1990 728 735
25. D. Goldblatt, R.J. Levinsky, and M.W. Turner Role of cell wall polysaccharide in the assessment of IgG antibodies to the capsular polysaccharides of Streptococcus pneumoniae in childhood J Infect Dis 166 3 1992 632 634
26. S.A. Quataert, C.S. Kirch, L.J. Wiedl, D.C. Phipps, S. Strohmeyer, and C.O. Cimino Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S Clin Diagn Lab Immunol 2 5 1995 590 597
27. T. Takai, M. Ono, M. Hikida, H. Ohmori, and J.V. Ravetch Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice Nature 379 6563 1996 346 349
28. J.V. Ravetch Fc receptors Curr Opin Immunol 9 1 1997 121 125
29. D. Bogaert, R.H. Veenhoven, M. Sluijter, E.A. Sanders, R. de Groot, and P.W. Hermans Colony blot assay: a useful method to detect multiple pneumococcal serotypes within clinical specimens FEMS Immunol Med Microbiol 41 3 2004 259 264
30. H. Faden, L. Duffy, R. Wasielewski, J. Wolf, D. Krystofik, and Y. Tung Relationship between nasopharyngeal colonization and the development of otitis media in children. Tonawanda/Williamsville Pediatrics J Infect Dis 175 6 1997 1440 1445
31. L.A. Sanders, R.G. Feldman, M.M. Voorhorst-Ogink, M. De Haas, G.T. Rijkers, and P.J. Capel Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils Infect Immun 63 1 1995 73 81
32. M.E. Rodriguez, W.L. van der Pol, L.A. Sanders, and J.G. van de Winkel Crucial role of FcgammaRIIa (CD32) in assessment of functional anti-Streptococcus pneumoniae antibody activity in human sera J Infect Dis 179 2 1999 423 433
33. E.A. Sanders, J.G. van de Winkel, R.G. Feldman, M.M. Voorhorst-Ogink, G.T. Rijkers, and P.J. Capel Fc gamma IIA receptor phenotype and opsonophagocytosis in two patients with recurrent bacterial infections Immunodeficiency 4 1-4 1993 163 165
34. W.T. Jansen, M.A. Breukels, H. Snippe, L.A. Sanders, A.F. Verheul, and G.T. Rijkers Fcgamma receptor polymorphisms determine the magnitude of in vitro phagocytosis of Streptococcus pneumoniae mediated by pneumococcal conjugate sera J Infect Dis 180 3 1999 888 891